title: Would you save this patient's eye or his brain?
authors.forename: Nitin K
authors.initials: NK
authors.lastname: Sethi
authors.forename: Josh
authors.initials: J
authors.lastname: Torgovnick
authors.forename: Prahlad K
authors.initials: PK
authors.lastname: Sethi
authors.forename: Edward
authors.initials: E
authors.lastname: Arsura
mesh_terms: D000208:Acute Disease / Q000628:therapy; D001037:Aphasia / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D001766:Blindness / Q000139:chemically induced / Q000517:prevention & control; D002545:Brain Ischemia / Q000150:complications / Q000628:therapy*; D002985:Clinical Protocols; D000075202:Contraindications; D003657:Decision Making; D004632:Emergency Medical Services / Q000379:methods / Q000592:standards; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000592:standards; D007049:Iatrogenic Disease / Q000517:prevention & control; D020244:Infarction, Middle Cerebral Artery / Q000150:complications / Q000628:therapy*; D007275:Injections, Intravenous / Q000009:adverse effects / Q000592:standards; D018570:Risk Assessment; D017131:Thrombectomy / Q000379:methods / Q000592:standards; D015912:Thrombolytic Therapy / Q000379:methods* / Q000592:standards; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D014656:Vascular Surgical Procedures / Q000379:methods / Q000592:standards; D014823:Vitreous Hemorrhage / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator